JP2003517041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003517041A5 JP2003517041A5 JP2001545542A JP2001545542A JP2003517041A5 JP 2003517041 A5 JP2003517041 A5 JP 2003517041A5 JP 2001545542 A JP2001545542 A JP 2001545542A JP 2001545542 A JP2001545542 A JP 2001545542A JP 2003517041 A5 JP2003517041 A5 JP 2003517041A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- seq
- phosphodiester nucleotide
- synthetic phosphodiester
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002773 nucleotide Substances 0.000 description 12
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003667 hormone antagonist Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17032599P | 1999-12-13 | 1999-12-13 | |
| US60/170,325 | 1999-12-13 | ||
| US22892500P | 2000-08-29 | 2000-08-29 | |
| US60/228,925 | 2000-08-29 | ||
| PCT/CA2000/001467 WO2001044465A2 (en) | 1999-12-13 | 2000-12-12 | Therapeutically useful synthetic oligonucleotides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003517041A JP2003517041A (ja) | 2003-05-20 |
| JP2003517041A5 true JP2003517041A5 (cg-RX-API-DMAC7.html) | 2008-02-07 |
| JP4772245B2 JP4772245B2 (ja) | 2011-09-14 |
Family
ID=26865979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001545542A Expired - Fee Related JP4772245B2 (ja) | 1999-12-13 | 2000-12-12 | 治療上有用な合成オリゴヌクレオチド |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7157436B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1867718B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4772245B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100829646B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN100445380C (cg-RX-API-DMAC7.html) |
| AT (2) | ATE370231T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU785212B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2393808A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ20022372A3 (cg-RX-API-DMAC7.html) |
| DE (2) | DE60036019T2 (cg-RX-API-DMAC7.html) |
| DK (2) | DK1238070T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2288883T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0300627A3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL150196A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA02005842A (cg-RX-API-DMAC7.html) |
| NO (1) | NO330508B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1238070E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001044465A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030032610A1 (en) | 1996-06-03 | 2003-02-13 | Gilchrest Barbara A. | Method to inhibit cell growth using oligonucleotides |
| US8114850B2 (en) | 1999-04-08 | 2012-02-14 | Advanced Cancer Therapeutics, Llc | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| US7960540B2 (en) | 1999-04-08 | 2011-06-14 | Advanced Cancer Therapeutics, Llc | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| PT1181304E (pt) | 1999-04-08 | 2008-01-23 | Antisoma Res Ltd | Actividade antiproliferativa de oligonucleótidos ricos em g e método de utilização dos mesmos para ligação a nucleolina |
| US6949520B1 (en) * | 1999-09-27 | 2005-09-27 | Coley Pharmaceutical Group, Inc. | Methods related to immunostimulatory nucleic acid-induced interferon |
| DE60036019T2 (de) * | 1999-12-13 | 2008-05-29 | Bioniche Life Sciences Inc., Belleville | Synthetische oligonukleotide die therapeutisch nützlich sind |
| JP2004507469A (ja) | 2000-08-29 | 2004-03-11 | バイオニケ ライフ サイエンシーズ インコーポレイテッド | Fasおよびfasl発現の調整 |
| WO2002069369A2 (en) * | 2000-12-08 | 2002-09-06 | Coley Pharmaceutical Gmbh | Cpg-like nucleic acids and methods of use thereof |
| US7087586B2 (en) * | 2001-04-24 | 2006-08-08 | Bioniche Life Sciences, Inc. | Oligonucleotide compositions and their use to induce differentiation of cells |
| DE60211206T2 (de) * | 2001-08-17 | 2006-10-26 | Bioniche Life Sciences Inc., Belleville | Zusammenhang zwischen konformation und biologischer aktivität von apoptose induzierenden phosphodiesteroligonukleotiden |
| IL161181A0 (en) | 2001-10-03 | 2004-08-31 | Bioniche Life Sciences Inc | Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| CN101160399A (zh) * | 2002-04-22 | 2008-04-09 | 拜奥尼茨生命科学公司 | 寡核苷酸组合物及其在调节免疫应答中的应用 |
| EP1608403A2 (en) * | 2003-04-02 | 2005-12-28 | Coley Pharmaceutical Group, Ltd. | Immunostimulatory nucleic acid oil-in-water formulations for topical application |
| KR20060012622A (ko) * | 2003-05-16 | 2006-02-08 | 하이브리돈, 인코포레이티드 | 화학요법제와 함께 이뮤노머를 사용하는 상승적 암 치료방법 |
| WO2006091915A2 (en) * | 2005-02-24 | 2006-08-31 | Coley Pharmaceutical Group, Inc. | Immunostimulatory oligonucleotides |
| EP1863538A4 (en) * | 2005-03-09 | 2009-01-14 | Baylor College Medicine | DIRECT INVERSION OF CD4 + T CELL LYMPHOCYTE INHIBITOR FUNCTION VIA TOLL-TYPE 8 RECEIVER SIGNALING |
| GB2443591B (en) * | 2005-09-07 | 2010-04-28 | Secr Defence | Adjuvanted vaccine |
| JP6066035B2 (ja) * | 2009-02-12 | 2017-01-25 | クルナ・インコーポレーテッド | グリア細胞由来神経栄養因子(gdnf)関連疾病の、gdnfに対する天然アンチセンス転写物の抑制による治療 |
| GB0906234D0 (en) | 2009-04-14 | 2009-05-20 | Secr Defence | Vaccine |
| KR100998365B1 (ko) | 2009-06-29 | 2010-12-06 | 압타바이오 주식회사 | 치료 효능이 있는 변형핵산 및 구아노신을 함유하는 올리고뉴클레오티드 변형체 |
| EP2490767A4 (en) * | 2009-07-15 | 2013-02-13 | Santaris Pharma As | OBJECTIVE RNA ANTAGONISTS FOR THE TREATMENT OF LEUKEMIA ON GLI2 |
| EP2821504A4 (en) * | 2012-02-28 | 2016-02-17 | Univ Tokyo Nat Univ Corp | METHOD FOR DETERMINING A DISEASE RELATED TO TDP-43 CONCENTRATION IN CELLS |
| EP4000597A1 (en) * | 2020-11-17 | 2022-05-25 | The Boots Company plc | Tetrapeptide and compositions comprising tetrapeptides |
| WO2023122762A1 (en) * | 2021-12-22 | 2023-06-29 | Camp4 Therapeutics Corporation | Modulation of gene transcription using antisense oligonucleotides targeting regulatory rnas |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3172815A (en) * | 1962-04-24 | 1965-03-09 | Warner Lambert Pharmaceutical | Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof |
| FR2160326B1 (cg-RX-API-DMAC7.html) * | 1971-11-19 | 1975-02-07 | Anvar | |
| US4152423A (en) * | 1971-11-19 | 1979-05-01 | Agence Nationale De Valorisation De La Recherche (Anvar) | Immunological agents |
| CA1020460A (en) * | 1973-02-23 | 1977-11-08 | Wellcome Foundation Limited (The) | Isolation of immunostimulating glycopeptide from bacteria |
| US3976544A (en) * | 1973-06-19 | 1976-08-24 | The Agence Nationale De Valorisation De Le Recherche | Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction |
| FR2374042A1 (fr) * | 1976-06-04 | 1978-07-13 | Merieux Inst | Nouveau medicament immunostimulant et son procede de preparation |
| JPS54140710A (en) * | 1978-03-10 | 1979-11-01 | Mitsui Toatsu Chem Inc | Anti-tumor substance and its preparation |
| DE3011461C2 (de) * | 1980-03-25 | 1986-10-30 | Dr. Madaus & Co, 5000 Köln | Verwendung von Propionibakterien |
| US4520019A (en) * | 1982-04-29 | 1985-05-28 | Ribi Immunochem Research, Inc. | Stable composition and preparation thereof |
| US4579941A (en) * | 1982-08-13 | 1986-04-01 | Mitsuitoatsu Chemicals, Inc. | Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent |
| US4663306A (en) * | 1983-09-23 | 1987-05-05 | Ribi Immunochem Research, Inc. | Pyridine-soluble extract-refined detoxified endotoxin composition and use |
| GB8404280D0 (en) * | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
| DE3423234A1 (de) * | 1984-06-23 | 1986-02-06 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Synergistische mischungen von interferonen und tumor-nekrose-faktor |
| US4744984A (en) * | 1985-10-08 | 1988-05-17 | Vetrepharm Research, Inc. | Antiviral immunotherapeutic agent and preparation thereof |
| US4877611A (en) * | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| DE3723075A1 (de) * | 1987-07-11 | 1989-01-19 | Boehringer Mannheim Gmbh | Eukaryotische expressionsvektoren mit multimeren enhancer-subelementen, verfahren zu ihrer herstellung und verwendung |
| US4958013A (en) * | 1989-06-06 | 1990-09-18 | Northwestern University | Cholesteryl modified oligonucleotides |
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| WO1992007095A1 (en) * | 1990-10-15 | 1992-04-30 | Stratagene | Arbitrarily primed polymerase chain reaction method for fingerprinting genomes |
| IL101038A0 (en) * | 1991-02-21 | 1992-11-15 | Gilead Sciences Inc | Agent specific for trombin and its use |
| EP0952855B1 (en) * | 1991-07-03 | 2005-07-27 | Meditech Research Limited | Use of hyaluronan in gene therapy |
| US5582981A (en) * | 1991-08-14 | 1996-12-10 | Gilead Sciences, Inc. | Method for identifying an oligonucleotide aptamer specific for a target |
| US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| IL107150A0 (en) * | 1992-09-29 | 1993-12-28 | Isis Pharmaceuticals Inc | Oligonucleotides having a conserved g4 core sequence |
| AU691797B2 (en) * | 1993-01-29 | 1998-05-28 | Vetrepharm, Inc. | Immunotherapeutic composition |
| US5567604A (en) * | 1993-04-23 | 1996-10-22 | Aronex Pharmaceuticals, Inc. | Anti-viral guanosine-rich oligonucleotides |
| CN1154702A (zh) * | 1994-05-25 | 1997-07-16 | 海布里登公司 | 具有抗巨细胞病毒活性的寡核苷酸 |
| DE69533037T2 (de) * | 1994-08-30 | 2005-05-04 | Commonwealth Scientific And Industrial Research Organisation | Pflanzentraskriptionsregulator von circovirus |
| US5643890A (en) | 1995-01-31 | 1997-07-01 | The Board Of Regents Of The University Of Nebraska | Synthetic oligonucleotides which mimic telomeric sequences for use in treatment of cancer and other diseases |
| IN181358B (cg-RX-API-DMAC7.html) * | 1995-02-14 | 1998-05-30 | Bioniche Inc | |
| ZA964446B (en) * | 1995-06-06 | 1996-12-06 | Hoffmann La Roche | Oligonucleotides specific for hepatitis c virus |
| US5990299A (en) * | 1995-08-14 | 1999-11-23 | Icn Pharmaceuticals, Inc. | Control of CD44 gene expression for therapeutic use |
| CN1202900A (zh) * | 1995-11-21 | 1998-12-23 | Icn药品公司 | 用il-8和il-8受体的反义寡核苷酸抑制肿瘤生长 |
| IT1277025B1 (it) * | 1995-12-04 | 1997-11-04 | Cooperativa Centro Ricerche Po | Classe di oligonucleotidi fosfodiesterici ad attivita' citotossica composizioni farmaceutiche che li contengono e loro uso |
| US6015710A (en) * | 1996-04-09 | 2000-01-18 | The University Of Texas System | Modulation of mammalian telomerase by peptide nucleic acids |
| WO1997044064A2 (en) * | 1996-05-20 | 1997-11-27 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Oligonucleotides which specifically bind retroviral nucleocapsid proteins |
| KR100533576B1 (ko) * | 1997-08-05 | 2005-12-05 | 바이오니취 라이프 사이언시즈 인코포레이티드 | 세포증식 및 세포사멸 조절용 조성물 및 방법 |
| US6255473B1 (en) * | 1997-08-29 | 2001-07-03 | Duke University | Presenilin-1 gene promoter |
| WO2001022972A2 (en) * | 1999-09-25 | 2001-04-05 | University Of Iowa Research Foundation | Immunostimulatory nucleic acids |
| DE60036019T2 (de) * | 1999-12-13 | 2008-05-29 | Bioniche Life Sciences Inc., Belleville | Synthetische oligonukleotide die therapeutisch nützlich sind |
| US20020091095A1 (en) * | 1999-12-13 | 2002-07-11 | Phillips Nigel C. | Modulation of Fas and FasL expression |
| US7125858B2 (en) * | 1999-12-28 | 2006-10-24 | Bioniche Life Sciences Inc. | Hyaluronic acid in the treatment of cancer |
| IL161181A0 (en) * | 2001-10-03 | 2004-08-31 | Bioniche Life Sciences Inc | Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| CN101160399A (zh) * | 2002-04-22 | 2008-04-09 | 拜奥尼茨生命科学公司 | 寡核苷酸组合物及其在调节免疫应答中的应用 |
-
2000
- 2000-12-12 DE DE60036019T patent/DE60036019T2/de not_active Expired - Lifetime
- 2000-12-12 ES ES00981117T patent/ES2288883T3/es not_active Expired - Lifetime
- 2000-12-12 JP JP2001545542A patent/JP4772245B2/ja not_active Expired - Fee Related
- 2000-12-12 US US09/735,363 patent/US7157436B2/en not_active Expired - Fee Related
- 2000-12-12 EP EP07015976A patent/EP1867718B1/en not_active Expired - Lifetime
- 2000-12-12 PT PT00981117T patent/PT1238070E/pt unknown
- 2000-12-12 KR KR1020027007557A patent/KR100829646B1/ko not_active Expired - Fee Related
- 2000-12-12 WO PCT/CA2000/001467 patent/WO2001044465A2/en not_active Ceased
- 2000-12-12 MX MXPA02005842A patent/MXPA02005842A/es active IP Right Grant
- 2000-12-12 DE DE60043759T patent/DE60043759D1/de not_active Expired - Lifetime
- 2000-12-12 AT AT00981117T patent/ATE370231T1/de active
- 2000-12-12 AU AU18479/01A patent/AU785212B2/en not_active Ceased
- 2000-12-12 AT AT07015976T patent/ATE455851T1/de not_active IP Right Cessation
- 2000-12-12 CN CNB008188580A patent/CN100445380C/zh not_active Expired - Fee Related
- 2000-12-12 CA CA002393808A patent/CA2393808A1/en not_active Abandoned
- 2000-12-12 DK DK00981117T patent/DK1238070T3/da active
- 2000-12-12 CN CN2008101740188A patent/CN101491536B/zh not_active Expired - Fee Related
- 2000-12-12 EP EP00981117A patent/EP1238070B1/en not_active Expired - Lifetime
- 2000-12-12 CZ CZ20022372A patent/CZ20022372A3/cs unknown
- 2000-12-12 ES ES07015976T patent/ES2340807T3/es not_active Expired - Lifetime
- 2000-12-12 HU HU0300627A patent/HUP0300627A3/hu unknown
- 2000-12-12 IL IL15019600A patent/IL150196A0/xx unknown
- 2000-12-12 DK DK07015976.9T patent/DK1867718T3/da active
-
2002
- 2002-06-12 IL IL150196A patent/IL150196A/en not_active IP Right Cessation
- 2002-06-13 NO NO20022820A patent/NO330508B1/no not_active IP Right Cessation
-
2006
- 2006-12-18 US US11/641,542 patent/US20070213291A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ522326A (en) | Adenosine A2A receptor antagonists | |
| JP2002535332A5 (cg-RX-API-DMAC7.html) | ||
| JP2002532222A5 (cg-RX-API-DMAC7.html) | ||
| HUP0300527A3 (en) | Pyrrolopyrimidinone derivatives, process of preparation and use | |
| AU2001280597A1 (en) | Compositions for sustained release of analgesic agents, and methods of making and using the same | |
| JP2002510633A5 (cg-RX-API-DMAC7.html) | ||
| EP1074549A3 (en) | Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors | |
| IL155966A0 (en) | Benzothiophene derivative compounds, process of preparation and use thereof | |
| AU2002305236A8 (en) | Composition, formulations and kits for treatment of respiratory and lung disease with anti-sense oligonucleotides and a bronchodilating agent | |
| HK1052346A1 (zh) | 有效用作β-2-肾上腺素受体激动剂以及PDE4-抑制剂的化合物 | |
| ZA200106102B (en) | Use of growth hormone secretagogues for improvement of functional health status. | |
| ZA200105293B (en) | Use of growth hormone secretagogues for treatment of physical performance decline. | |
| AU2001264044A1 (en) | 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof | |
| JP2002522501A5 (cg-RX-API-DMAC7.html) | ||
| JP2002506864A5 (cg-RX-API-DMAC7.html) | ||
| GB0110061D0 (en) | Novel 4,5-Dihydroisoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor and preparation thereof | |
| JP2002540769A5 (cg-RX-API-DMAC7.html) | ||
| HUP0204554A3 (en) | Endoparasiticidal composition, preparation and use thereof | |
| USD449421S1 (en) | Woman's necktie | |
| CA2353205A1 (en) | Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient | |
| MXPA03004498A (es) | Uso de pirazolo (4,3-d)pirimidinas. | |
| ZA985277B (en) | Novel ß-amino and ß-azido carboxylic and acid derivatives, their preparation and use as endothelin receptor antagonists. | |
| JP2003516751A5 (cg-RX-API-DMAC7.html) | ||
| AU2002240248A1 (en) | Expandable, no-shrink shirt collar | |
| USD460840S1 (en) | Horse head collar |